Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Underwriting Agreement
- 3.3 Certificate of Incorporation of Adial Pharmaceuticals, Inc.
- 3.4 Bylaws of Adial Pharmaceuticals, Inc.
- 3.5 Articles of Incorporation of Apl Conversion Corp., a Virginia Stock Corporation
- 3.6 Bylaws of Apl Conversion Corp.
- 3.7 Entity Conversion Filed with the Virginia Secretary of State
- 3.8 Terms and Conditions of the Plan of Entity Conversion
- 3.9 Certificate of Merger Filed with the Delaware Secretary of State
- 3.10 Articles of Merger Filed with the Virginia Secretary of State
- 3.11 Agreement and Plan of Merger and Reorganization
- 3.12 First Amendment to the Second Amended and Restated Operating Agreement of Adial Pharmaceuticals, L.L.C., Dated As of September 22, 2017
- 4.1 Specimen Common Stock Certificate
- 4.14 Amendment to Senior Secured Promissory Note Dated As of October 23, 2017 by and Between Adial Pharmaceuticals, L.L.C. As Predecessor-in-interest to Adial Pharmaceuticals, Inc. and Firstfire Global Opportunities Fund, LLC
- 5.1 Opinion of Gracin & Marlow, LLP
- 23.1 Consent of Friedman LLP
ADIL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-220368) of our report dated May 11, 2017, which includes an explanatory paragraph as to the company’s ability to continue as going concern, with respect to the financial statements of ADial Pharmaceuticals, L.L.C. as of December 31, 2016 and 2015 and for the years then ended. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ Friedman LLP
East Hanover, New Jersey
October 25, 2017